Tetsuya Suhara
#156,446
Most Influential Person Now
Tetsuya Suhara's AcademicInfluence.com Rankings
Tetsuya Suharacomputer-science Degrees
Computer Science
#8637
World Rank
#9081
Historical Rank
Computer Graphics
#169
World Rank
#174
Historical Rank
Database
#5636
World Rank
#5849
Historical Rank

Download Badge
Computer Science
Tetsuya Suhara's Degrees
- Doctorate Medicine Institute of Science Tokyo
Why Is Tetsuya Suhara Influential?
(Suggest an Edit or Addition)Tetsuya Suhara's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands (2007) (1854)
- Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model (2007) (1409)
- Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET (1997) (719)
- Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls (2013) (671)
- Linearized Reference Tissue Parametric Imaging Methods: Application to [11C]DASB Positron Emission Tomography Studies of the Serotonin Transporter in Human Brain (2003) (594)
- When Your Gain Is My Pain and Your Pain Is My Gain: Neural Correlates of Envy and Schadenfreude (2009) (437)
- Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET (2009) (302)
- Longitudinal, Quantitative Assessment of Amyloid, Neuroinflammation, and Anti-Amyloid Treatment in a Living Mouse Model of Alzheimer's Disease Enabled by Positron Emission Tomography (2007) (293)
- Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders (2008) (254)
- Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease (1997) (243)
- Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors. (1995) (229)
- Increased Binding of Peripheral Benzodiazepine Receptor in Alzheimer's Disease Measured by Positron Emission Tomography with [11C]DAA1106 (2008) (209)
- Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation (2008) (206)
- Dopamine D2 Receptors in the Insular Cortex and the Personality Trait of Novelty Seeking (2001) (204)
- Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia. (2002) (200)
- Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model (2007) (190)
- A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients (1997) (188)
- Age-related degeneration of corpus callosum measured with diffusion tensor imaging (2006) (186)
- Pet study of [11C] β‐CIT binding to monoamine transporters in the monkey and human brain (1994) (181)
- Functional Brain Mapping of Monkey Tool Use (2001) (178)
- Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106. (2010) (172)
- Reduced volume of the cerebellar vermis in neuroleptic-naive schizophrenia (2001) (171)
- No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET (2003) (167)
- Imaging of Peripheral Benzodiazepine Receptor Expression as Biomarkers of Detrimental versus Beneficial Glial Responses in Mouse Models of Alzheimer's and Other CNS Pathologies (2008) (164)
- Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies (2017) (162)
- Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: An imaging tool for glial cells in the brain (2004) (157)
- Differential Contributions of Prefrontal and Hippocampal Dopamine D1 and D2 Receptors in Human Cognitive Functions (2008) (156)
- Age-related changes in human D1 dopamine receptors measured by positron emission tomography (2005) (154)
- Serotonin transporter binding in patients with mood disorders: a PET study with [11C](+)McN5652 (2002) (151)
- Pharmacokinetics and brain uptake of lactoferrin in rats. (2006) (150)
- Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo. (2004) (149)
- Deficiency of Schnurri-2, an MHC Enhancer Binding Protein, Induces Mild Chronic Inflammation in the Brain and Confers Molecular, Neuronal, and Behavioral Phenotypes Related to Schizophrenia (2013) (142)
- [(11)C]DAA1106: radiosynthesis and in vivo binding to peripheral benzodiazepine receptors in mouse brain. (2003) (139)
- Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor (2007) (138)
- P301S Mutant Human Tau Transgenic Mice Manifest Early Symptoms of Human Tauopathies with Dementia and Altered Sensorimotor Gating (2011) (138)
- Increased binding of peripheral benzodiazepine receptor in mild cognitive impairment–dementia converters measured by positron emission tomography with [11C]DAA1106 (2012) (138)
- Age-related reduction of extrastriatal dopamine D2 receptor measured by PET. (2001) (136)
- Development of a new radioligand, N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl)acetamide, for pet imaging of peripheral benzodiazepine receptor in primate brain. (2004) (134)
- Men and women show distinct brain activations during imagery of sexual and emotional infidelity (2006) (128)
- Brain activations during judgments of positive self-conscious emotion and positive basic emotion: pride and joy. (2008) (128)
- Radiosynthesis, Photoisomerization, Biodistribution, and Metabolite Analysis of 11C-PBB3 as a Clinically Useful PET Probe for Imaging of Tau Pathology (2014) (126)
- Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia. (2004) (125)
- Inhibitory effect of hippocampal 5-HT1A receptors on human explicit memory. (2003) (124)
- In Vivo Positron Emission Tomographic Imaging of Glial Responses to Amyloid-β and Tau Pathologies in Mouse Models of Alzheimer's Disease and Related Disorders (2011) (123)
- High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography. (2003) (121)
- Effects of dopaminergic and serotonergic manipulation on emotional processing: A pharmacological fMRI study (2005) (117)
- Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study. (1993) (117)
- D1 dopamine receptor binding in mood disorders measured by positron emission tomography (2005) (106)
- Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys (2019) (105)
- Dose-finding study of paliperidone ER based on striatal and extrastriatal dopamine D2 receptor occupancy in patients with schizophrenia (2008) (104)
- Extrastriatal dopamine D2 receptor density and affinity in the human brain measured by 3D PET. (1999) (104)
- A dose-finding study of duloxetine based on serotonin transporter occupancy (2006) (103)
- Decreased 5-HT1A receptor binding in amygdala of schizophrenia (2004) (99)
- Reconstruction magnetic resonance neurography in chronic inflammatory demyelinating polyneuropathy (2015) (97)
- Memory and frontal lobe functions; possible relations with dopamine D2 receptors in the hippocampus (2007) (96)
- Age-related decline of serotonin transporters in living human brain of healthy males. (2002) (95)
- It’s Not My Fault: Postdictive Modulation of Intentional Binding by Monetary Gains and Losses (2012) (94)
- PET Quantification of Tau Pathology in Human Brain with 11C-PBB3 (2015) (94)
- Quantitative analyses of 18F-FEDAA1106 binding to peripheral benzodiazepine receptors in living human brain. (2006) (93)
- Functional and structural synergy for resolution recovery and partial volume correction in brain PET (2009) (92)
- Apathy correlates with prefrontal amyloid β deposition in Alzheimer's disease (2013) (91)
- High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer’s and Non-Alzheimer’s Disease Tauopathies (2020) (91)
- Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of age (1999) (91)
- Mechanistic involvement of the calpain‐calpastatin system in Alzheimer neuropathology (2012) (90)
- Evaluation of in vivo P-glycoprotein function at the blood-brain barrier among MDR1 gene polymorphisms by using 11C-verapamil. (2006) (89)
- A comparison of the high‐affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)‐PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation (2007) (87)
- Lung as reservoir for antidepressants in pharmacokinetic drug interactions (1998) (87)
- Glial cell-mediated deterioration and repair of the nervous system after traumatic brain injury in a rat model as assessed by positron emission tomography. (2010) (84)
- In Vivo Evaluation of P-glycoprotein Function at the Blood-Brain Barrier in Nonhuman Primates Using [11C]Verapamil (2006) (83)
- Regional cerebral blood flow changes associated with interoceptive awareness in the recovery process of anorexia nervosa (2006) (82)
- [18F]FMDAA1106 and [18F]FEDAA1106: two positron-emitter labeled ligands for peripheral benzodiazepine receptor (PBR). (2003) (82)
- Quantitative Analysis for Estimating Binding Potential of the Peripheral Benzodiazepine Receptor with [11C]DAA1106 (2007) (80)
- Relationship Between Neuroticism Personality Trait and Serotonin Transporter Binding (2007) (80)
- Normal database of dopaminergic neurotransmission system in human brain measured by positron emission tomography (2008) (77)
- Quantification of Dopamine Transporter in Human Brain Using PET with 18F-FE-PE2I (2012) (76)
- The Role of Extrastriatal Dopamine D2 Receptors in Schizophrenia (2006) (75)
- Age-related decline of dopamine synthesis in the living human brain measured by positron emission tomography with l-[β-11C]DOPA (2006) (75)
- Reduced serotonin transporter binding in the insular cortex in patients with obsessive–compulsive disorder: A [11C]DASB PET study (2010) (75)
- Serotonin 5-HT2 receptors in schizophrenic patients studied by positron emission tomography. (2000) (74)
- Isolation and transplantation of dopaminergic neurons generated from mouse embryonic stem cells (2004) (74)
- Brain muscarinic receptors in progressive supranuclear palsy and Parkinson’s disease: a positron emission tomographic study (1998) (73)
- Association between Aβ and tau accumulations and their influence on clinical features in aging and Alzheimer's disease spectrum brains: A [11C]PBB3-PET study (2016) (73)
- 11C-AC-5216: A Novel PET Ligand for Peripheral Benzodiazepine Receptors in the Primate Brain (2007) (73)
- Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neurons (2016) (70)
- Enhanced dopamine release by nicotine in cigarette smokers: a double-blind, randomized, placebo-controlled pilot study. (2008) (70)
- Reproducibility of [11C]FLB 457 binding in extrastriatal regions (2001) (69)
- Functional significance of central D1 receptors in cognition: beyond working memory (2012) (69)
- PET imaging-guided chemogenetic silencing reveals a critical role of primate rostromedial caudate in reward evaluation (2016) (67)
- PET Mapping of Extrastriatal D2-like Dopamine Receptors in the Human Brain Using an Anatomic Standardization Technique and [11C]FLB 457 (1999) (66)
- Effects of repetitive transcranial magnetic stimulation on [11C]raclopride binding and cognitive function in patients with depression. (2006) (66)
- In vivo detection of neuropathologic changes in presymptomatic MAPT mutation carriers: a PET and MRI study. (2010) (66)
- Regional dopamine synthesis in patients with schizophrenia using L-[β-11C]DOPA PET (2009) (65)
- In vivo binding properties of [carbonyl‐11C]WAY‐100635: Effect of endogenous serotonin (2001) (65)
- β‐amyloid in lewy body disease is related to Alzheimer's disease‐like atrophy (2013) (64)
- Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia. (2010) (63)
- Regional cerebral blood flow in depressed patients with white matter magnetic resonance hyperintensity (2003) (63)
- Template-Based Method for Multiple Volumes of Interest of Human Brain PET Images (2002) (63)
- Relation among dopamine D2 receptor binding, obesity and personality in normal human subjects (2001) (62)
- Hierarchical order of coexisting pre- and postsynaptic forms of long-term potentiation at synapses in amygdala (2010) (62)
- Quantitative magnetic resonance spectroscopy of schizophrenia: Relationship between decreased N‐acetylaspartate and frontal lobe dysfunction (2006) (62)
- Age-related changes in human muscarinic acetylcholine receptors measured by positron emission tomography (1993) (59)
- Ten year progressive ventricular enlargement in schizophrenia: An MRI morphometrical study (2001) (58)
- Effect of endogenous dopamine on extrastriatal [11C]FLB 457 binding measured by PET (2001) (58)
- Electroconvulsive therapy decreases dopamine D₂receptor binding in the anterior cingulate in patients with depression: a controlled study using positron emission tomography with radioligand [¹¹C]FLB 457. (2010) (56)
- Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia. (2010) (55)
- Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models (2018) (53)
- Correlation between quantitative imaging and behavior in unilaterally 6-OHDA-lesioned rats (2005) (53)
- A Primary Role for Nucleus Accumbens and Related Limbic Network in Vocal Tics (2016) (52)
- Phosphorylation and gene expression of p53 are not affected in human cells exposed to 2.1425 GHz band CW or W‐CDMA modulated radiation allocated to mobile radio base stations (2006) (52)
- Estimation of the time-course of dopamine D2 receptor occupancy in living human brain from plasma pharmacokinetics of antipsychotics. (2004) (51)
- Effects of sports participation on psychiatric symptoms and brain activations during sports observation in schizophrenia (2012) (50)
- Dopamine D1 Receptors and Nonlinear Probability Weighting in Risky Choice (2010) (50)
- Honesty mediates the relationship between serotonin and reaction to unfairness (2012) (50)
- Dopamine D1 receptor number — a sensitive PET marker for early brain degeneration in Huntington's disease (2005) (50)
- High-contrast in-vivo imaging of tau pathologies in Alzheimer’s and non-Alzheimer’s disease tauopathies (2020) (50)
- Neural correlates of human virtue judgment. (2008) (49)
- Quantitative Analysis of Norepinephrine Transporter in the Human Brain Using PET with (S,S)-18F-FMeNER-D2 (2008) (48)
- Decreased binding of [11C]NNC112 and [11C]SCH23390 in patients with chronic schizophrenia. (2010) (47)
- In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510. (2018) (46)
- Maternal immune activation by polyriboinosinic-polyribocytidilic acid injection produces synaptic dysfunction but not neuronal loss in the hippocampus of juvenile rat offspring (2010) (46)
- Quantitative analysis of 11C-verapamil transfer at the human blood-brain barrier for evaluation of P-glycoprotein function. (2006) (46)
- GABAA/Benzodiazepine receptor binding in patients with schizophrenia using [11C]Ro15-4513, a radioligand with relatively high affinity for α5 subunit (2008) (46)
- Steroidogenic abnormalities in translocator protein knockout mice and significance in the aging male. (2018) (45)
- Effect of electroconvulsive therapy on 5-HT1A receptor binding in patients with depression: a PET study with [11C]WAY 100635. (2010) (45)
- An Alteration in the Lateral Geniculate Nucleus of Experimental Glaucoma Monkeys: In vivo Positron Emission Tomography Imaging of Glial Activation (2012) (43)
- Relation between Presynaptic and Postsynaptic Dopaminergic Functions Measured by Positron Emission Tomography: Implication of Dopaminergic Tone (2011) (43)
- Chronic Fluoxetine Selectively Upregulates Dopamine D1-Like Receptors in the Hippocampus (2012) (42)
- Error Analysis for Quantification of [11C]FLB 457 Binding to Extrastriatal D2 Dopamine Receptors in the Human Brain (2001) (42)
- Contribution of Dopamine D1 and D2 Receptors to Amygdala Activity in Human (2010) (40)
- Neural circuits in the brain that are activated when mitigating criminal sentences (2012) (40)
- Serotonergic neurotransmission in the living human brain: A positron emission tomography study using [11C]dasb and [11C]WAY100635 in young healthy men (2011) (40)
- The antipsychotic sultopride is overdosed--a PET study of drug-induced receptor occupancy in comparison with sulpiride. (2006) (40)
- PET-detectable tau pathology correlates with long-term neuropsychiatric outcomes in patients with traumatic brain injury. (2019) (39)
- Effects of the Antipsychotic Risperidone on Dopamine Synthesis in Human Brain Measured by Positron Emission Tomography with l-[β-11C]DOPA: A Stabilizing Effect for Dopaminergic Neurotransmission? (2009) (38)
- Norepinephrine in the brain is associated with aversion to financial loss (2013) (38)
- Neurobehavioral protection by single dose l-deprenyl against MPTP-induced parkinsonism in common marmosets (2007) (38)
- Dose relationship of limbic-cortical D2-dopamine receptor occupancy with risperidone (2001) (38)
- Altered brain activation by a false recognition task in young abstinent patients with alcohol dependence. (2007) (38)
- In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer’s disease (2019) (37)
- Guidelines for the content and format of PET brain data in publications and archives: A consensus paper (2020) (37)
- Reduced gray matter volume of dorsal cingulate cortex in patients with obsessive–compulsive disorder: A voxel‐based morphometric study (2010) (36)
- Estimation of Plasma IC50 of Donepezil for Cerebral Acetylcholinesterase Inhibition in Patients With Alzheimer Disease Using Positron Emission Tomography (2010) (35)
- Increase in thalamic binding of [(11)C]PE2I in patients with schizophrenia: a positron emission tomography study of dopamine transporter. (2009) (35)
- Norepinephrine Transporter in Major Depressive Disorder: A PET Study. (2017) (35)
- Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model (2020) (35)
- Superiority illusion arises from resting-state brain networks modulated by dopamine (2013) (35)
- Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2). (2013) (35)
- Possible role of dopamine D1 receptors in schizophrenia (1997) (33)
- Norepinephrine transporter occupancy by antidepressant in human brain using positron emission tomography with (S,S)-[18F]FMeNER-D2 (2010) (33)
- Role of Ventral Striatal Dopamine D1 Receptor in Cigarette Craving (2007) (33)
- Synthesis and evaluation of N-(5-fluoro-2-phenoxyphenyl)-N-(2-[(18)F]fluoromethoxy-d(2)-5-methoxybenzyl)acetamide: a deuterium-substituted radioligand for peripheral benzodiazepine receptor. (2005) (33)
- Macaque prefrontal activity associated with extensive tool use (2002) (33)
- Primary functional brain connections associated with melancholic major depressive disorder and modulation by antidepressants (2020) (33)
- Synthesis, in vitro and in vivo pharmacology of a C-11 labeled analog of CP-101,606, (+/-)threo-1-(4-hydroxyphenyl)-2-[4-hydroxy-4-(p-[11C]methoxyphenyl)piperidino]-1-propanol, as a PET tracer for NR2B subunit-containing NMDA receptors. (2002) (32)
- Neuroimaging and Physiological Evidence for Involvement of Glutamatergic Transmission in Regulation of the Striatal Dopaminergic System (2009) (32)
- Occupancy of Norepinephrine Transporter by Duloxetine in Human Brains Measured by Positron Emission Tomography with (S,S)-[18F]FMeNER-D2 (2017) (32)
- Differential effects of acute and chronic treatment with typical and atypical neuroleptics on c-fos mRNA expression in rat forebrain regions using non-radioactive in situ hybridization (1999) (32)
- [2-11C]isopropyl-, [1-11C]ethyl-, and [11C]methyl-labeled phenoxyphenyl acetamide derivatives as positron emission tomography ligands for the peripheral benzodiazepine receptor: radiosynthesis, uptake, and in vivo binding in brain. (2006) (32)
- Muscarinic cholinergic receptors in human narcolepsy (1998) (31)
- Effects of Dopamine D2 Receptor Partial Agonist Antipsychotic Aripiprazole on Dopamine Synthesis in Human Brain Measured by PET with L-[β-11C]DOPA (2012) (31)
- Progressive changes of pre‐ and post‐synaptic dopaminergic biomarkers in conscious MPTP‐treated cynomolgus monkeys measured by positronemission tomography (2007) (31)
- Time Course of In Vivo 5-HTT Transporter Occupancy by Fluvoxamine (2006) (31)
- Visualization of α5 subunit of GABAA/benzodiazepine receptor by [11C]Ro15‐4513 using positron emission tomography (2003) (31)
- Impact of spillover from white matter by partial volume effect on quantification of amyloid deposition with [11C]PiB PET (2016) (31)
- Quantitative Analysis for Estimating Binding Potential of the Brain Serotonin Transporter with [11C]McN5652 (2002) (31)
- Quantification of Central Substance P Receptor Occupancy by Aprepitant Using Small Animal Positron Emission Tomography (2015) (30)
- In Vivo SPECT Imaging of Amyloid-β Deposition with Radioiodinated Imidazo[1,2-a]Pyridine Derivative DRM106 in a Mouse Model of Alzheimer's Disease (2014) (30)
- Hypersensitivity of cortical muscarinic receptors in Parkinson's disease demonstrated by PET (1995) (30)
- Enhanced activation in the extrastriate body area by goal‐directed actions (2008) (30)
- PET study of the M1-agonists [11C]xanomeline and [11C]butylthio-TZTP in monkey and man. (1996) (30)
- Dementia with Lewy bodies can be well‐differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity—a [11C]MP4A PET study (2015) (29)
- No age-related changes in human benzodiazepine receptor binding measured by PET with [11C]Ro 15-4513 (1993) (29)
- In vivo binding of a tau imaging probe, [11C]PBB3, in patients with progressive supranuclear palsy (2019) (29)
- Age-related decline of dopamine synthesis in the living human brain measured by positron emission tomography with L-[beta-11C]DOPA. (2006) (28)
- Relationship between baseline cerebral blood flow and vascular responses to changes in PaCO2 measured by positron emission tomography in humans: implication of inter‐individual variations of cerebral vascular tone (2008) (28)
- Total body 100-mGy X-irradiation does not induce Alzheimer's disease-like pathogenesis or memory impairment in mice (2013) (28)
- Effect of desipramine on dopamine receptor binding in vivo. (1990) (28)
- Quantitative analysis of dopamine synthesis in human brain using positron emission tomography with L-[&bgr;-11C]DOPA (2006) (27)
- Biochemical Distribution of Tau Protein in Synaptosomal Fraction of Transgenic Mice Expressing Human P301L Tau (2014) (27)
- Imaging for metabotropic glutamate receptor subtype 1 in rat and monkey brains using PET with [18F]FITM (2012) (27)
- In vivo binding of [11C]Ro15-4513 in human brain measured with PET (1992) (26)
- Distinct microglial response against Alzheimer's amyloid and tau pathologies characterized by P2Y12 receptor (2021) (26)
- Amyloid imaging with [18F]florbetapir in geriatric depression: early‐onset versus late‐onset (2015) (26)
- Development of efficient packaging method of oligodeoxynucleotides by a condensed nano particle in lipid envelope structure. (2005) (26)
- Synthesis and preliminary PET study of the 5‐HT7 receptor antagonist [11C]DR4446 (2002) (26)
- Cerebral serotonin transporter measurements with [11C]DASB: A review on acquisition and preprocessing across 21 PET centres (2019) (26)
- No regional difference in dopamine D2 receptor occupancy by the second-generation antipsychotic drug risperidone in humans: a positron emission tomography study. (2009) (26)
- Carbon-11-methionine positron emission tomography imaging of chordoma (2004) (25)
- [11C]Methionine Positron Emission Tomography and Survival in Patients with Bone and Soft Tissue Sarcomas Treated by Carbon Ion Radiotherapy (2004) (25)
- Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia (2017) (25)
- Tau-induced focal neurotoxicity and network disruption related to apathy in Alzheimer’s disease (2018) (25)
- Quantitative Analysis of Peripheral Benzodiazepine Receptor in the Human Brain Using PET with 11C-AC-5216 (2009) (25)
- Quantitative analysis of dopamine transporters in human brain using [11C]PE2I and positron emission tomography: evaluation of reference tissue models (2010) (25)
- Multimodal Imaging for DREADD-Expressing Neurons in Living Brain and Their Application to Implantation of iPSC-Derived Neural Progenitors (2016) (25)
- Mobile phone base station radiation does not affect neoplastic transformation in BALB/3T3 cells (2008) (24)
- Assessment of neuroinflammation in a mouse model of obesity and β-amyloidosis using PET (2016) (24)
- Clozapine can induce high dopamine D2 receptor occupancy in vivo (2002) (24)
- Signaling Incentive and Drive in the Primate Ventral Pallidum for Motivational Control of Goal-Directed Action (2018) (24)
- Functional network in the prefrontal cortex during episodic memory retrieval (2005) (24)
- Different roles of group I and group II metabotropic glutamate receptors on phencyclidine-induced dopamine release in the rat prefrontal cortex (2003) (23)
- A prodrug of NMDA/glycine site antagonist, L-703,717, with improved BBB permeability: 4-acetoxy derivative and its positron-emitter labeled analog. (2001) (23)
- Syntheses and pharmacological evaluation of two potent antagonists for dopamine D4 receptors: [11C]YM-50001 and N-[2-[4-(4-Chlorophenyl)-piperizin-1-yl]ethyl]-3-[11C]methoxybenzamide. (2002) (23)
- Imaging Multimodalities for Dissecting Alzheimer's Disease: Advanced Technologies of Positron Emission Tomography and Fluorescence Imaging (2015) (23)
- Time course of dopamine D2 receptor occupancy by clozapine with medium and high plasma concentrations (2006) (23)
- Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[¹⁸F]FMeNER-D₂. (2014) (23)
- Chronic lithium chloride injection increases glucocorticoid receptor but not mineralocorticoid receptor mRNA expression in rat brain (2000) (23)
- Characterization of 1‐(2‐[18F]fluoro‐3‐pyridyl)‐4‐(2‐isopropyl‐1‐oxo‐ isoindoline‐5‐yl)‐5‐methyl‐1H‐1,2,3‐triazole, a PET ligand for imaging the metabotropic glutamate receptor type 1 in rat and monkey brains (2012) (23)
- Neural basis of negativity bias in the perception of ambiguous facial expression (2017) (23)
- First prototyping of a dedicated PET system with the hemisphere detector arrangement (2019) (23)
- Test-retest reproducibility of dopamine D2/3 receptor binding in human brain measured by PET with [11C]MNPA and [11C]raclopride (2013) (23)
- PET imaging of colony-stimulating factor 1 receptor: A head-to-head comparison of a novel radioligand, 11C-GW2580, and 11C-CPPC, in mouse models of acute and chronic neuroinflammation and a rhesus monkey (2021) (22)
- PET Analysis of Dopaminergic Neurodegeneration in Relation to Immobility in the MPTP-Treated Common Marmoset, a Model for Parkinson’s Disease (2012) (22)
- Principal Component Analysis of Multimodal Neuromelanin MRI and Dopamine Transporter PET Data Provides a Specific Metric for the Nigral Dopaminergic Neuronal Density (2016) (22)
- Synthesis and evaluation of novel radioligands for positron emission tomography imaging of the orexin-2 receptor. (2013) (21)
- Fronto-parieto-cerebellar interaction associated with intermanual transfer of monkey tool-use learning (2003) (21)
- Brain and whole body distribution ofN-isopropyl-4-iodoamphetamine (I-123) in humans: Comparison of radiopharmaceuticals marketed by different companies in Japan (2006) (21)
- Measurement of glycine binding site of N‐methyl‐d‐asparate receptors in living human brain using 4‐acetoxy derivative of L‐703,717, 4‐acetoxy‐7‐chloro‐3‐[3‐(4‐[11c] methoxybenzyl) phenyl]‐2(1H)‐quinolone (AcL703) with positron emission tomography (2007) (21)
- Effects of endogenous agonists, glycine and D‐serine, on in vivo specific binding of [11C]L‐703,717, a PET radioligand for the glycine‐binding site of NMDA receptors (2003) (21)
- Assessment of radioligands for PET imaging of cyclooxygenase-2 in an ischemic neuronal injury model (2013) (21)
- Quantitative PET Analysis of the Dopamine D2 Receptor Agonist Radioligand 11C-(R)-2-CH3O-N-n-Propylnorapomorphine in the Human Brain (2009) (21)
- Abnormal axon guidance signals and reduced interhemispheric connection via anterior commissure in neonates of marmoset ASD model (2019) (21)
- Quantitative Analysis of Amyloid Deposition in Alzheimer Disease Using PET and the Radiotracer 11C-AZD2184 (2014) (20)
- Imaging of amyloid deposition in human brain using positron emission tomography and [18F]FACT: comparison with [11C]PIB (2014) (20)
- In-vivo visualization of key molecular processes involved in Alzheimer's disease pathogenesis: Insights from neuroimaging research in humans and rodent models. (2010) (20)
- Chemogenetic dissection of the primate prefronto-subcortical pathways for working memory and decision-making (2021) (20)
- Synthesis and evaluation of 3-(4-chlorobenzyl)-8-[11C]methoxy-1,2,3,4-tetrahydrochromeno[3,4-c]pyridin-5-one: a PET tracer for imaging sigma1 receptors (2002) (20)
- Development of Novel PET Probes for Central 2-Amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic Acid Receptors. (2015) (20)
- PET Quantification of the Norepinephrine Transporter in Human Brain with (S,S)-18F-FMeNER-D2 (2016) (20)
- Laterality and aging of thalamic subregions measured by diffusion tensor imaging (2007) (19)
- Development of 1-N-11C-Methyl-l- and -d-Tryptophan for pharmacokinetic imaging of the immune checkpoint inhibitor 1-Methyl-Tryptophan (2015) (19)
- In vivo mapping of substance P receptors in brains of laboratory animals by high‐resolution imaging systems (2007) (19)
- Chronic repetitive transcranial magnetic stimulation failed to change dopamine synthesis rate: Preliminary L‐[β‐11C]DOPA positron emission tomography study in patients with depression (2010) (18)
- In vivo drug action of tandospirone at 5-HT1A receptor examined using positron emission tomography and neuroendocrine response (2002) (18)
- Vocalizations associated with anxiety and fear in the common marmoset (Callithrix jacchus) (2014) (18)
- Changes in central 5-HT1A receptor binding in mesial temporal epilepsy measured by positron emission tomography with [11C]WAY100635 (2007) (18)
- A human PET study of [11C]HMS011, a potential radioligand for AMPA receptors (2017) (18)
- Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel‐based analysis for entorhinal cortex atrophy (2015) (18)
- N-(5-Fluoro-2-phenoxyphenyl)-N-(2-[(131)I]iodo-5-me thoxybenzyl)acetamide: a potent iodinated radioligand for the peripheral-type benzodiazepine receptor in brain. (2007) (17)
- Possible Role of Organic Cation Transporters in the Distribution of [11C]Sulpiride, a Dopamine D2 Receptor Antagonist. (2017) (17)
- Classification of Clinically Diagnosed Alzheimer's Disease Associated with Diabetes Based on Amyloid and Tau PET Results. (2019) (17)
- Striatal and extrastriatal dopamine D2 receptor occupancy by the partial agonist antipsychotic drug aripiprazole in the human brain: a positron emission tomography study with [11C]raclopride and [11C]FLB457 (2012) (16)
- Reproducibility of PET measurement for presynaptic dopaminergic functions using L-[&bgr;-11C]DOPA and [18F]FE-PE2I in humans (2014) (16)
- Development of TASP0410457 (TASP457), a novel dihydroquinolinone derivative as a PET radioligand for central histamine H3 receptors (2016) (16)
- A new method to quantify tau pathologies with 11C-PBB3 PET using reference tissue voxels extracted from brain cortical gray matter (2016) (16)
- Relation between Dopamine Synthesis Capacity and Cell-Level Structure in Human Striatum: A Multi-Modal Study with Positron Emission Tomography and Diffusion Tensor Imaging (2014) (16)
- Regulation of Anxiety and Depression by Mitochondrial Translocator Protein-Mediated Steroidogenesis: the Role of Neurons (2020) (16)
- Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features (2019) (16)
- Tau imaging detects distinctive distribution of tau pathology in ALS/PDC on the Kii Peninsula (2018) (15)
- Mapping of central dopamine synthesis in man, using positron emission tomography with l-[β-11C]DOPA (2007) (15)
- Effect of risperidone on high-affinity state of dopamine D2 receptors: a PET study with agonist ligand [11C](R)-2-CH3O-N-n-propylnorapomorphine. (2011) (15)
- Binding of Dopamine D1 Receptor and Noradrenaline Transporter in Individuals with Autism Spectrum Disorder: A PET Study. (2020) (15)
- Enhancing Multi-Center Generalization of Machine Learning-Based Depression Diagnosis From Resting-State fMRI (2019) (15)
- PRECLINICAL STUDY: Different effects of chronic phencyclidine on brain‐derived neurotrophic factor in neonatal and adult rat brains (2006) (15)
- Utility of small-animal positron emission tomographic imaging of rats for preclinical development of drugs acting on the serotonin transporter. (2009) (15)
- Normative data of dopaminergic neurotransmission functions in substantia nigra measured with MRI and PET: Neuromelanin, dopamine synthesis, dopamine transporters, and dopamine D2 receptors (2017) (15)
- Distinct binding of amyloid imaging ligands to unique amyloid‐β deposited in the presubiculum of Alzheimer's disease (2015) (15)
- In vivo and in vitro imaging of I2 imidazoline receptors in the monkey brain (2011) (15)
- Simultaneous quantification of two brain functions with dual tracer injection in PET dynamic study (2004) (15)
- Quantitative and Noninvasive Assessment of Prenatal X-Ray-Induced CNS Abnormalities Using Magnetic Resonance Imaging (2011) (14)
- Strategies for Utilizing Neuroimaging Biomarkers in CNS Drug Discovery and Development: CINP/JSNP Working Group Report (2016) (14)
- In Vivo PET Measurements with [11C]PE2I to Evaluate Fetal Mesencephalic Transplantations to Unilateral 6-OHDA-Lesioned Rats (2005) (14)
- Neuroticism Associates with Cerebral in Vivo Serotonin Transporter Binding Differently in Males and Females (2017) (14)
- 19F‐magnetic resonance spectroscopy and chemical shift imaging for schizophrenic patients using haloperidol decanoate (2002) (14)
- Development of N-[11C]methylamino 4-hydroxy-2(1H)-quinolone derivatives as PET radioligands for the glycine-binding site of NMDA receptors. (2009) (14)
- Hydration level is an internal variable for computing motivation to obtain water rewards in monkeys (2012) (14)
- Regional heterogeneity and age-related change in sub-regions of internal capsule evaluated by diffusion tensor imaging (2010) (14)
- Abnormal effective connectivity of dopamine D2 receptor binding in schizophrenia (2005) (14)
- In-vivo PET imaging of inducible D2R reporter transgene expression using [11C]FLB 457 as reporter probe in living rats (2005) (14)
- Alterations in the expressions of mRNA for GDNF and its receptors in the ventral midbrain of rats exposed to subchronic phencyclidine. (2004) (13)
- Development of the helmet-chin PET prototype (2015) (13)
- Amyloid and Tau Positron Emission Tomography in Suggested Diabetesrelated Dementia. (2018) (13)
- Quantitative assessment of central nervous system disorder induced by prenatal X‐ray exposure using diffusion and manganese‐enhanced MRI (2012) (13)
- Quantitative Analysis of NK1 Receptor in the Human Brain Using PET with 18F-FE-SPA-RQ (2008) (13)
- [11C]metaraminol, a false neurotransmitter: preparation, metabolite studies and positron emission tomography examination in monkey. (1996) (13)
- Tau oligomers as potential targets for early diagnosis of tauopathy. (2014) (13)
- Reserpine-induced reduction of in vivo binding of SCH 23390 and N-methylspiperone and its reversal by d-amphetamine. (1991) (13)
- [11C]TASP457, a novel PET ligand for histamine H3 receptors in human brain (2016) (13)
- Effects of trihexyphenidyl and L-dopa on brain muscarinic cholinergic receptor binding measured by positron emission tomography (1994) (13)
- Functional Organization of Monkey Brain for Abstract Operation (2007) (12)
- Association between Brain and Plasma Glutamine Levels in Healthy Young Subjects Investigated by MRS and LC/MS (2019) (12)
- Synthesis and biological evaluation of novel radioiodinated imidazopyridine derivatives for amyloid-β imaging in Alzheimer's disease. (2014) (12)
- Seizure frequency and bilateral temporal abnormalities: a proton magnetic resonance spectroscopy of temporal lobe epilepsy (2000) (12)
- Measurement of dopamine D2 receptors in living human brain using [11C]raclopride with ultra-high specific radioactivity. (2010) (12)
- Chemogenetic activation of nigrostriatal dopamine neurons in freely moving common marmosets (2021) (12)
- Wavelet denoising for voxel-based compartmental analysis of peripheral benzodiazepine receptors with 18F-FEDAA1106 (2008) (12)
- Development of 123I-labelled NNC 13-8241 as a radioligand for SPECT visualization of benzodiazepine receptor binding. (1996) (12)
- Design, synthesis, radiolabeling, and in vivo evaluation of carbon-11 labeled N-[2-[4-(3-cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a potential positron emission tomography tracer for the dopamine D(4) receptors. (2010) (12)
- Synthesis of 11C-labelled bis(phenylalkyl)amines and their in vitro and in vivo binding properties in rodent and monkey brains. (2004) (12)
- In vivo evaluation of cellular activity in αCaMKII heterozygous knockout mice using manganese-enhanced magnetic resonance imaging (MEMRI) (2013) (12)
- Role of left superior temporal gyrus during name recall process: An event-related fMRI study (2008) (12)
- Evaluation of semi-quantitative method for quantification of dopamine transporter in human PET study with 18F-FE-PE2I (2015) (12)
- Correlation between decreased motor activity and dopaminergic degeneration in the ventrolateral putamen in monkeys receiving repeated MPTP administrations: A positron emission tomography study (2012) (11)
- A new graphic plot analysis for determination of neuroreceptor binding in positron emission tomography studies (2010) (11)
- Difference in brain distributions of carbon 11-labeled 4-hydroxy-2(1H)-quinolones as PET radioligands for the glycine-binding site of the NMDA ion channel. (2008) (11)
- Neonatal phencyclidine treatment selectively attenuates mesolimbic dopamine function in adult rats as revealed by methamphetamine‐induced behavior and c‐fos mRNA expression in the brain (2001) (11)
- Bromine-76 and carbon-11 labelled NNC 13-8199, metabolically stable benzodiazepine receptor agonists as radioligands for positron emission tomography (PET) (1997) (11)
- Dopamine D 1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study (11)
- A positron‐emitter labeled glycineB site antagonist, [11C]L‐703,717, preferentially binds to a cerebellar NMDA receptor subtype consisting of GluR ϵ3 subunit in vivo, but not in vitro (2002) (11)
- Striatal and extrastriatal dopamine D 2 receptor occupancy by the partial agonist antipsychotic drug aripiprazole in the human brain: a positron emission tomography study (2012) (10)
- Muscarinic receptor occupancy by biperiden in living human brain. (1999) (10)
- A high-yield automated radiosynthesis of the alpha-7 nicotinic receptor radioligand [18F]NS10743. (2015) (10)
- A migration case of Kii amyotrophic lateral sclerosis/parkinsonism dementia complex with the shortest stay in the endemic area and the longest incubation to develop the disease (2017) (10)
- Differentiation Between Dementia With Lewy Bodies And Alzheimer’s Disease Using Voxel-Based Morphometry Of Structural MRI: A Multicenter Study (2019) (10)
- Detection of Alzheimer’s disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein (2021) (10)
- In vivo positron emission tomography imaging of mitochondrial abnormalities in a mouse model of tauopathy (2020) (10)
- Molecular imaging of dementia (2012) (10)
- Nitric Oxide Signaling Exerts Bidirectional Effects on Plasticity Inductions in Amygdala (2013) (10)
- Neuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy (2021) (10)
- Presynaptic Selectivity of a Ligand for Serotonin 1A Receptors Revealed by In Vivo PET Assays of Rat Brain (2012) (10)
- Effects of menopause on brain structural changes in schizophrenia (2013) (10)
- Swim stress alters in vivo binding of [3H]N-methylspiperone (1991) (10)
- Excess tau PET ligand retention in elderly patients with major depressive disorder (2020) (9)
- Microglial Activation During Pathogenesis of Tauopathy in rTg4510 Mice: Implications for the Early Diagnosis of Tauopathy. (2018) (9)
- Neuroimaging in dementia: in vivo amyloid imaging. (2008) (9)
- Biological evaluation of the radioiodinated imidazo[1,2-a]pyridine derivative DRK092 for amyloid-β imaging in mouse model of Alzheimer's disease (2014) (9)
- Low‐dose total‐body carbon‐ion irradiations induce early transcriptional alteration without late Alzheimer's disease‐like pathogenesis and memory impairment in mice (2014) (9)
- Voxel-Based Acetylcholinesterase PET Study in Early and Late Onset Alzheimer's Disease. (2018) (9)
- Chemogenetic sensory fMRI reveals behaviorally relevant bidirectional changes in primate somatosensory network (2021) (9)
- Error analysis for PET measurement of dopamine D2 receptor occupancy by antipsychotics with [11C]raclopride and [11C]FLB 457 (2008) (9)
- Amyloid β accumulation assessed with ¹¹C-Pittsburgh compound B PET and postmortem neuropathology. (2015) (9)
- Effects of image reconstruction algorithm on neurotransmission PET studies in humans: Comparison between filtered backprojection and ordered subsets expectation maximization (2006) (9)
- In Vivo Tau Imaging for a Diagnostic Platform of Tauopathy Using the rTg4510 Mouse Line (2017) (9)
- Metabolite analysis of [11C]Ro15-4513 in mice, rats, monkeys and humans. (2003) (8)
- Anatomical relationships between serotonin 5-HT2A and dopamine D2 receptors in living human brain (2017) (8)
- Effects of cocaine on [11C]norepinephrine and [11C]β-CIT uptake in the primate peripheral organs measured by PET (1996) (8)
- Monkey brain areas underlying remote‐controlled operation (2004) (8)
- Dopamine D2 receptor occupancy by perospirone: a positron emission tomography study in patients with schizophrenia and healthy subjects (2010) (8)
- Extrastriatal dopamine D2 receptor occupancy in olanzapine-treated patients with schizophrenia (2010) (8)
- 7Li 2D CSI of human brain on a clinical scanner (2001) (8)
- Emergence of realism: Enhanced visual artistry and high accuracy of visual numerosity representation after left prefrontal damage (2014) (8)
- Development of radioligands for the dopamine transporter (1996) (8)
- A possible serologic biomarker for maternal immune activation-associated neurodevelopmental disorders found in the rat models (2016) (8)
- Visualization of alpha5 subunit of GABAA/benzodiazepine receptor by 11C Ro15-4513 using positron emission tomography. (2003) (8)
- In vivo tau PET imaging using [11C]PBB3 in Alzheimer’s disease and non-Alzheimer’s disease tauopathies (2014) (8)
- Comparative evaluation of two serotonin transporter ligands in the human brain: [11C](+)McN5652 and [11C]cyanoimipramine (2002) (7)
- No inhibitory effect on P-glycoprotein function at blood–brain barrier by clinical dose of clarithromycin: a human PET study with [11C]verapamil (2010) (7)
- Decreased 5-HT 1A Receptor Binding in Amygdala of (2004) (7)
- Increased binding of 5-HT1A receptors in a dissociative amnesic patient after the recovery process (2014) (7)
- Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model mice (2020) (7)
- Quantitative analyses of [11C]Ro15-4513 binding to subunits of GABAA/benzodiazepine receptor in the living human brain (2009) (7)
- In vivo imaging of neuroinflammation in Alzheimer's disease (2016) (7)
- Synthesis and evaluation of 18F- and 11C-labelled 9,10-ethanobenzo[b]quinolizinium derivatives for imaging of the NMDA receptor at the TCP-binding site (2000) (7)
- Phosphorous-31 magnetic resonance spectroscopy of cervical cancer using transvaginal surface coil. (2005) (7)
- Pharmacological and Genetic Inhibition of Translocator Protein 18 kDa Ameliorated Neuroinflammation in Murine Endotoxemia Model. (2020) (7)
- [An improved automated synthesis and in vivo evaluation of PET radioligand for serotonin re-uptake sites: [11C]McN5652X]. (1996) (7)
- Effect of radiolabeled metabolite elimination from the brain on the accuracy of cerebral enzyme activity estimation using positron emission tomography with substrate tracers (2011) (7)
- [Imaging blood-brain barrier function by using positron emission tomography to evaluate drug penetration into the brain]. (2013) (6)
- Imaging of Neuronal Activity in Awake Mice by Measurements of Flavoprotein Autofluorescence Corrected for Cerebral Blood Flow (2018) (6)
- Positron emission tomography shows high specific uptake of racemic carbon-11 labelled norepinephrine in the primate heart (1994) (6)
- Relation between cortical dopamine D2 receptor occupancy and suppression of conditioned avoidance response in non‐human primate (2004) (6)
- Neonatal treatment with l-name (ng-nitro-l-arginine methyl ester) attenuates stereotyped behavior induced by acute methamphetamine but not development of behavioral sensitization to methamphetamine (2000) (6)
- Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model mice (2020) (6)
- Tau Fibril Formation in Cultured Cells Compatible with a Mouse Model of Tauopathy (2018) (6)
- A Small-Animal Pharmacokinetic/Pharmacodynamic PET Study of Central Serotonin 1A Receptor Occupancy by a Potential Therapeutic Agent for Overactive Bladder (2013) (6)
- Heavy Tau Burden with Subtle Amyloid β Accumulation in the Cerebral Cortex and Cerebellum in a Case of Familial Alzheimer’s Disease with APP Osaka Mutation (2020) (6)
- Behavioral / Systems / Cognitive Dopamine D 1 Receptors and Nonlinear Probability Weighting in Risky Choice (2010) (6)
- High-Contrast PET Imaging of Vasopressin V1B Receptors with a Novel Radioligand, 11C-TASP699 (2017) (6)
- Animal models of tauopathies (2006) (5)
- Correction of head movement by frame-to-frame image realignment for receptor imaging in positron emission tomography studies with [11C]raclopride and [11C]FLB 457 (2019) (5)
- Synthesis and characterization of 11 C-labeled benzyl amidine derivatives as PET radioligands for GluN2B subunit of the NMDA receptors. (2018) (5)
- Longitudinal [11C]PIB PET study in healthy elderly persons, patients with mild cognitive impairment, and Alzheimer's disease (2011) (5)
- Identifying melancholic depression biomarker using whole-brain functional connectivity (2017) (5)
- Biodistribution and radiation dosimetry in humans of [¹¹C]FLB 457, a positron emission tomography ligand for the extrastriatal dopamine D₂ receptor. (2014) (5)
- [Pulmonary kinetics of 13N-ammonia in smoking subjects--a quantitative study using dynamic PET]. (1992) (5)
- IMAGING OF TAU PATHOLOGY IN PATIENTS WITH NON-ALZHEIMER'S DISEASE TAUOPATHIES BY [11C]PBB3-PET (2014) (5)
- Histamine H3 receptor density is negatively correlated with neural activity related to working memory in humans (2018) (5)
- Diagnostic Utility and Clinical Significance of Tau PET imaging with [11C]PBB3 in Diverse Tauopathies (2015) (5)
- In vivo optical and PET detections of fibrillar tau lesions in a mouse model of tauopathies (2009) (5)
- Comparative evaluation of two serotonin transporter ligands in the human brain: [(11)C](+)McN5652 and [(11)C]cyanoimipramine. (2002) (4)
- In vitro evidence for competitive tspo binding of the imaging biomarker candidates vinpocetine and two iodinated daa1106 analogues in post mortem autoradiography experiments on whole hemisphere human brain slices (2009) (4)
- Recurrent hyperperfusion in the right orbitofrontal cortex in obsessive–compulsive disorder (2008) (4)
- Prediction of CNS occupancy of dopamine D2 receptor based on systemic exposure and in vitro experiments. (2016) (4)
- Synthesis and evaluation of 3-(4-chlorobenzyl)-8-[11C]methoxy-1,2,3,4-tetrahydrochromeno[3,4-c]pyridin-5-one: a PET tracer for imaging sigma(1) receptors. (2002) (4)
- In vivo PET imaging of the behaviorally active designer receptor in macaque monkeys (2014) (4)
- Single caudate neurons encode temporally discounted value for formulating motivation for action (2020) (4)
- Staging of tau distribution by positron emission tomography may be useful in clinical staging of Alzheimer disease (2020) (4)
- Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients (2022) (4)
- Publisher Correction: Primary functional brain connections associated with melancholic major depressive disorder and modulation by antidepressants (2020) (4)
- Beyond PIB: the next generation of amyloid‐imaging ligands (2008) (4)
- In vivo visualization of tau pathology (2013) (4)
- Dynamic alterations in the central glutamatergic status following food and glucose intake: in vivo multimodal assessments in humans and animal models (2021) (4)
- Effects of the reference tissue setting on the parametric image of 11C-WAY 100635 (2007) (4)
- [Effect of aging on in vivo binding of 11C-N-methylspiperone in living human frontal cortex]. (1991) (3)
- TASP0434299: A Novel Pyridopyrimidin-4-One Derivative as a Radioligand for Vasopressin V1B Receptor (2016) (3)
- Effect of Cooperation Level of Group on Punishment for Non-Cooperators: A Functional Magnetic Resonance Imaging Study (2012) (3)
- Neuroimaging in psychiatry: Current methods and future direction (2016) (3)
- Central role for p62/SQSTM1 in the elimination of toxic tau species in a mouse model of tauopathy (2022) (3)
- Inverse correlation between body mass index and serotonin transporter binding in human brain: A [11C]DASB PET study (2008) (3)
- Visual evaluation of kinetic characteristics of PET probe for neuroreceptors using a two-phase graphic plot analysis (2017) (3)
- D1- and D2-like receptors differentially mediate the effects of dopaminergic transmission on cost/benefit evaluation and motivation in monkeys (2021) (3)
- Radiosynthesis and in vivo Evaluation of Carbon‐11 (2S)‐3‐(1H‐Indol‐3‐yl)‐2‐{[(4‐methoxyphenyl)carbamoyl]amino}‐N‐{[1‐(5‐methoxypyridin‐2‐yl)cyclohexyl]methyl}propanamide: An Attempt to Visualize Brain Formyl Peptide Receptors in Mouse Models of Neuroinflammation (2016) (3)
- [Distribution and function of dopamine D1, D2 receptor]. (2007) (3)
- AGE-RELATED WHITE MATTER PATHOGENESIS IN A MOUSE MODEL OF TAUOPATHY (2014) (3)
- High‐Contrast Imaging of α‐Synuclein Pathologies in Living Patients with Multiple System Atrophy (2022) (3)
- An acute effect of triazolam on muscarinic cholinergic receptor binding in the human brain measured by positron emission tomography (2005) (3)
- Synthesis and brain regional distribution of [11C]NPS 1506 in mice and rat: an N-methyl-D-aspartate (NMDA) receptor antagonist. (2003) (3)
- New radioligands for pet-examination of central muscarinic receptors (1994) (3)
- Evaluation of [11C]oseltamivir uptake into the brain during immune activation by systemic polyinosine-polycytidylic acid injection: a quantitative PET study using juvenile monkey models of viral infection (2014) (3)
- PET applications in animal models of neurodegenerative and neuroinflammatory disorders. (2012) (3)
- Two pathways differentially linking tau depositions, oxidative stress, and neuronal loss to apathetic phenotypes in progressive supranuclear palsy (2022) (3)
- Monkey brain activity modulated by reward preferences: A positron emission tomography study (2009) (3)
- Age correlates with cortical acetylcholinesterase decline in Alzheimer's disease patients: A PET study (2012) (3)
- Quantitative Measurement of Acetylcholinesterase Activity in Living Human Brain Using a Radioactive Acetylcholine Analog and Dynamic PET (1998) (3)
- [Pathophysiology of mood disorders and the therapy]. (2002) (3)
- PRECLINICAL AND CLINICAL CHARACTERIZATION OF 18F-PM-PBB3, A PET LIGAND FOR DIVERSE TAU PATHOLOGIES (2018) (2)
- IN VIVO PET IMAGING OF MITOCHONDRIAL ABNORMALITIES IN A MOUSE MODEL OF TAUOPATHY (2017) (2)
- [Evaluation of imaging biomarker by transgenic mouse models]. (2009) (2)
- Genetically targeted reporter imaging of deep neuronal network in the mammalian brain (2020) (2)
- Quantification of Neuroreceptors and Neurotransporters (2012) (2)
- Imaging Pituitary Vasopressin 1B Receptor in Humans with the PET Radiotracer 11C-TASP699 (2021) (2)
- IN VIVO TRACKING OF TAU PATHOLOGIES WITH 18F-PM-PBB3 (18F-APN-1607) PET IN AD AND DIVERSE NON-AD TAUOPATHIES (2019) (2)
- In vivo visualization of tau pathology in Alzheimer's disease patients by [11C]PBB3-PET (2013) (2)
- THE ASSOCIATION BETWEEN AB AND TAU ACCUMULATIONS AND ITS INFLUENCE ON CLINICAL FEATURES IN AGING AND ALZHEIMER’S DISEASE SPECTRUM BRAINS: [11C]PBB3 PET STUDY (2016) (2)
- Neural damage due to temporal lobe epilepsy: Dual‐nuclei (proton and phosphorus) magnetic resonance spectroscopy study (2004) (2)
- [11C]AC-5216: RADIOSYNTHESIS AND EVALUATION ASA NOVEL POSITRON EMISSION TOMOGRAPHY LIGAND FOR PERIPHERAL-TYPE BENZODIAZEPINE RECEPTORS IN PRIMATE BRAIN (2007) (2)
- Resting-state brain activity can predict target-independent aptitude in fMRI-neurofeedback training (2021) (2)
- Tracking tau fibrillogenesis and consequent primary phagocytosis of neurons mediated by microglia in a living tauopathy model (2020) (2)
- Relationship between regional gray matter volumes and dopamine D2 receptor and transporter in living human brains (2021) (2)
- Use of human methylation arrays for epigenome research in the common marmoset (Callithrix jacchus) (2017) (2)
- The necessary parameters for estimating the time-course of receptor occupancy. (2005) (2)
- Central Nervous System Drug Evaluation Using Positron Emission Tomography (2011) (2)
- Localized Accumulation of Tau without Amyloid-Beta in Aged Brains Measured with [11C]PBB3 and [11C]Pib Positron Emission Tomography (2017) (2)
- [Alzheimer's disease and microglia]. (2011) (2)
- Effect of sedative drugs upon receptor binding in vivo. (1992) (2)
- [11C]PBB3 PET VISUALIZES TAU AGGREGATES IN PATIENTS WITH FTDP-17 MAPT GENE MUTATION (2016) (2)
- In vivo optical and PET detections of fibrillar tau lesions in a mouse model of tauopathies (2009) (2)
- Pharmacokinetic and pharmacodynamic assessment of histamine H3 receptor occupancy by enerisant: a human PET study with a novel H3 binding ligand, [11C]TASP457 (2021) (2)
- Positron emission tomography inter-scanner differences in dopamine D2 receptor binding measured with [11C]FLB457 (2010) (2)
- In vivo visualization of tau pathology in Alzheimer's disease patients by [11c]PBB3-PET (2013) (2)
- Association between Striatal Subregions and Extrastriatal Regions in Dopamine D1 Receptor Expression: A Positron Emission Tomography Study (2012) (2)
- Initial clinical test of the first Helmet-Chin PET prototype for highly sensitive brain imaging (2016) (2)
- Quantification of peripheral benzodiazepine receptors using a new aryloxyanilide based ligand [11C]PBR28 in monkey and human (2007) (2)
- Neuromolecular basis of faded perception associated with unreality experience (2018) (2)
- Chemogenetic Disconnection between the Orbitofrontal Cortex and the Rostromedial Caudate Nucleus Disrupts Motivational Control of Goal-Directed Action (2022) (2)
- S-52-2 Imaging of the brain serotonin system (1996) (2)
- THE ASSOCIATION BETWEEN Aβ AND TAU ACCUMULATIONS AND ITS INFLUENCE ON CLINICAL FEATURES IN AGING AND ALZHEIMER’S DISEASE SPECTRUM BRAINS: [11C]PBB3 PET STUDY (2016) (2)
- PET-based classification of corticobasal syndrome. (2022) (2)
- Brain 5-HT2A receptor binding and its neural network related to behavioral inhibition system (2022) (2)
- [Receptor occupancy and antipsychotic drug action measured by PET and SPECT]. (2001) (1)
- Age correlates with cortical acetylcholinesterase decline in Alzheimer's disease patients: A PET study (2012) (1)
- SPECT IMAGING FOR AMYLOID PLAQUES WITH A NOVEL RADIOIODINATED LIGAND IN AN ALZHEIMER'S DISEASE MODEL (2014) (1)
- Noninvasive k 3 estimation method for slow dissociation PET ligands: application to ( 11 C) (2013) (1)
- Preparation of acute living hippocampal slice from common marmoset (Callithrix jacchus) for synaptic function analysis (2012) (1)
- O-12-6 Petstudies of D1 and D2 dopamine receptors in schizophrenic patients (1996) (1)
- Quantitative analysis of norepinephrine transporter binding in human brain using PET with (S,S)-[18F]FMeNER-D2 (2008) (1)
- Evaluation of error on parameter estimates in the quantitative analysis of receptor studies with positron emission tomography (2005) (1)
- 729. Delayed-Onset Psychosis following TBI is Associated with Tau Depositions in the Neocortex but Not with β-Amyloid Depositions: A Pet Study with [11C]PBB3 and [11C]PiB (2017) (1)
- D1Doparnine Receptor Binding in Mood Disorders Measured by PET (1992) (1)
- Estimation of time course of dopamine D2 receptor occupancy from plasma pharmacokinetics of antipsychotics (2003) (1)
- The high-affinity peripheral benzodiazepine receptor ligand [C-11]DAA1106 results in improved delineation of neuroinflammatory lesions in a rodent model of disease compared to [C-11]PK11195 (2006) (1)
- 74-8 Direct 2D-spectroscopic imaging of lithium in patients (1997) (1)
- ANTI-INFLAMMATORY EFFECT OF TSPO LIGAND IN MOUSE MODEL OF TAUOPATHY (2017) (1)
- Effects of smoking on the lung accumulation of [11C]McN5652 (2007) (1)
- emission tomography ligand for the extrastriatal dopamine D 2 receptor (2014) (1)
- A genetically targeted reporter for PET imaging of deep neuronal circuits in mammalian brains (2021) (1)
- [Molecular imaging of psychiatric disorders]. (2007) (1)
- Long‐term suppression of methamphetamine‐induced c‐Fos expression in rat striatum by the injection of c‐fos antisense oligodeoxynucleotides absorbed in water‐absorbent polymer (2004) (1)
- Dr. Yasuno and Colleagues Reply (2004) (1)
- TAU PET IMAGING IN ANIMAL MODELS AND HUMANS (2014) (1)
- D1- and D2-like receptors differentially mediate the effects of dopaminergic transmission on cost–benefit evaluation and motivation in monkeys (2021) (1)
- Resting-state functional connectivity relates to interindividual variations in positive memory (2021) (1)
- Quantitative analysis of dopamine D2 receptor binding in human brain using PET with an agonist radioligand [11C]MNPA (2008) (1)
- Amyloid-Negative Dementia in the Elderly is Associated with High Accumulation of Tau in the Temporal Lobes (2019) (1)
- Compensation, Insurance, and Management of Injuries in Investigator-Initiated Clinical Trials in Japan (2016) (1)
- AMYLOID AND TAU PET FINDINGS IN DIABETES-RELATED DEMENTIA (2016) (1)
- Evaluation of error on parameter estimates in the analysis of receptor studies with positron emission tomography (2005) (1)
- Effect of L-dopa and reserpine on in vivo binding of (3H)-SCH 23390 and (3H)-N-methylspiperone. (1991) (1)
- Measurement of glycine binding site of N-methyl-d-aspartate (NMDA) receptors in living human brain using 4-Acetoxy derivative of l-703,717, 4-Acetoxy-7-chloro-3-[3-(4-[11C] methoxybenzyl) phenyl]-2(1H)-quinolone (AcL703) with PET (2006) (1)
- [Pathophysiology and treatment of depression: a review of PET imaging of serotonin transporter. (2007) (1)
- Hippocampal dopamine D2 receptors are involved in memory and frontal lobe functions (2006) (1)
- Preparation and Examination of Labelled Stereoisomers in Vivo by Pet (1995) (1)
- TASP 0434299 : A Novel Pyridopyrimidin-4-One Derivative as a Radioligand for Vasopressin V 1 B Receptor (2016) (1)
- A database of the intraindividual presynaptic serotonin transporter and postsynaptic serotonin 1A receptor functions: A PET study with [C-11]WAY-100635 and [C-11]DASB (2008) (1)
- [Imaging of glial cells by positron-emitted peripheral benzodiazepine receptor ligands]. (2006) (1)
- Quantitative analysis of tau pathology in human brain using PET with [C-11]PBB3 (2015) (1)
- Behavioral characteristics of low-motivation and its relation to serotonin in a primate model of depression (2010) (1)
- Animal models of tauopathies. (2006) (1)
- Influence of O-Methylated Metabolite Penetrating the Blood–Brain Barrier to Estimation of Dopamine Synthesis Capacity in Human L-[β-11C]DOPA PET (2014) (1)
- Total-body low-dose irradiation of mice induces neither learning disability and memory impairment in Morris water maze test nor Alzheimer's disease-like pathogensis in the brain (2014) (1)
- Alpha-CaMKII deficiency causes dysregulated behaviours and immature dentate gyrus (2007) (0)
- Poster #162 EFFECT OF SPORTS PARTICIPATION ON BRAIN ACTIVATIONS DURING SPORTS OBSERVATION IN SCHIZOPHRENIA (2012) (0)
- Measurement of Striatal Dopamine Release Induced by Neuropsychological Stimulation in Positron Emission Tomography With Dual Injections of [11C]Raclopride (2022) (0)
- A new graphic plot method for determination of neuroreceptor binding in PET studies (2008) (0)
- The 42nd Annual Meeting of The Japanese Society of Neuroradiology, 15–16 February 2013, Kokura, Japan (2013) (0)
- Molecular imaging for motivational function and dysfunction (2011) (0)
- PET measurement of brain acetylcholinesterase activities in cortex and subcortical areas (2016) (0)
- Correction: Anatomical relationships between serotonin 5-HT2A and dopamine D2 receptors in living human brain (2018) (0)
- In-vivo Imaging of Neuronal Differentiation and Function of Intracranially Implanted Induced Pluripotent Stem Cells (iPSCs) Using A Designer Receptor Exclusively Activated by A Designer Drug (DREADD) (2014) (0)
- NEUROPROTECTIVE ACTION OF SINGLE DOSE DEPRENYL AGAINST MPTP-INDUCED PARKINSONISM IN COMMON MARMOSETS (2005) (0)
- PET Quantification in Molecular Brain Imaging Taking into Account the Contribution of the Radiometabolite Entering the Brain (2016) (0)
- AMYLOID AND TAU IMAGING IN PATIENTS WITH POSTERIOR CORTICAL ATROPHY (2018) (0)
- Effects of second-generation antipsychotic drug on dopamine synthesis in human brain measured by PET with L-[C-11]DOPA (2009) (0)
- Selective dysfunction of fast-spiking inhibitory interneurons and disruption of perineuronal nets in a tauopathy mouse model (2023) (0)
- PM371. Measurement of genomic copy number and DNA methylation levels of LINE-1 in the brains of poly(I:C) mouse model (2016) (0)
- [Molecular neuroimaging in schizophrenia]. (2013) (0)
- Positron emission tomography shows high specific uptake of racemic carbon-11 labelled norepinephrine in the primate heart (2004) (0)
- Contribution of Dopamine D1 and D2 Receptors to Amygdala Activity (2009) (0)
- TRANSLOCATOR PROTEIN AS A THERAPEUTIC TARGET FOR ALZHEIMER`S DISEASE (2015) (0)
- Evaluation of hippocampal degeneration after prenatal radiation exposure using Manganese-enhanced MRI ( MEMRI ) (2008) (0)
- Synthesis and evaluation of C‐11 labeled analog of CP‐101, 606 as a pet tracer for NR2B‐containing NMDA receptors (2001) (0)
- Superiority of Implicit Self-evaluation and Resting-State Functional Connectivity Network (2019) (0)
- Multimodal database of dopaminergic neurotransmission functions in substantia nigra measured by MRI and PET (2016) (0)
- Neural network of superiority illusion predicts the level of dopamine in striatum (2022) (0)
- [In vivo evaluation of expressed protein function by PET]. (2005) (0)
- Cortical amyloid deposition in Lewy body diseases with dementia demonstrated by PET (2009) (0)
- [11C]PBB3 PET detects tau pathology in corticobasal syndrome and progressive supranuclear palsy. (2015) (0)
- Regional differences in occupancy of dopamine D2 receptors by second-generation antipsychotics in humans measured using PET (2008) (0)
- Neural correlates of transmission from lexical-semantic to lexical-phonological stages during name recall: An event-related fMRI study (2008) (0)
- PET quantification of binding of a novel tau radioligand, 18F-AM-PBB3, in consideration of time-dependent changes in its plasma free fraction (2017) (0)
- [Molecular imaging for pharmacodynamics of psychotropic drugs]. (2007) (0)
- Contents of The American Journal of Psychiatry (2003) (0)
- INVESTIGATING THE LINK BETWEEN PATHOLOGICAL TAU ACCUMULATION, NEUROINFLAMMATION AND BRAIN ATROPHY IN A MODEL OF TAUOPATHY (2016) (0)
- Semi-automatic volumetrics system to parcellate ROI on neocortex (2002) (0)
- 2.021 DEMENTIA WITH LEWY BODIES CAN BE WELL-DIFFERENTIATED FROM ALZHEIMER'S DISEASE BY MEASUREMENT OF BRAIN ACETYLCHOLIN ESTERASE ACTIVITY BY PET (2012) (0)
- Evaluation of Optimal Scan Time by Bootstrap Approach for Quantitative Analysis in PET Receptor Study (2006) (0)
- [PET (positron emission tomography) research on schizophrenia]. (2006) (0)
- Development of therapies and monitoring against tauopathies with dementia (2010) (0)
- Utility of tau imaging probe pbb3 on a mouse model of tauopathy (2015) (0)
- In vivo detection of amyloid deposition using [11C]AZD2184 PET (2012) (0)
- Measurement of changes in endogenous serotonin level by positron emission tomography with [18F]altanserin (2021) (0)
- Imaging extra-striatal dopamine D2 receptors in a maternal immune activation rat model (2022) (0)
- Selective autophagy in neurons and its involvement in the tau pathogenesis (2011) (0)
- Possible value of Positron emission tomography for early diagnosis of Alzheimer disease (2003) (0)
- Neuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy (2021) (0)
- Does a single low dose of ionizing radiation induce Alzheimer's disease-like alterations in mice? (2012) (0)
- Wavelet DenoisingofDynamic PET Data: Application totheParametricImaging of PeripheralBenzodiazepineReceptor (2006) (0)
- Serial and simultaneous PET measurement of fetal nigral transplantation in hemi-Parkinson model rats with [11C]PE2I and [11C]raclopride (2005) (0)
- The high-affinity peripheral benzodiazepine receptor ligand [11C]DAA1106 can be used to image microglia in animal models of Parkinson's disease and neuroinflammation in vivo using PET: 48.4 (2007) (0)
- Regional distribution of high and low affinity states of dopamine D2/3 receptor binding in humans: A PET study using [11C]MNPA and [11C]raclopride (2010) (0)
- Correlation between cerebral blood flow and amyloid deposition in Alzheimer's disease studied by [11C]PIB PET (2010) (0)
- PET IMAGING OF SYNERGISTIC, BUT MODALLY DISTINCT OBESITY- AND AB-TRIGGERED ABNORMALITIES IN CEREBRAL GLUCOSE METABOLISM AND GLIOSIS IN MICE (2014) (0)
- [Biological pathophysiology of mood disorders special reference to the neurotransmitter receptors]. (2004) (0)
- Quantification of dopamine transporter in human brain using positron emission tomography with 18F-FE-PE2I (2012) (0)
- [Advances of neuroimaging research and the development of pathophysiology hypothesis for obsessive-compulsive disorder]. (2011) (0)
- Noninvasive k3 estimation method for slow dissociation PET ligands: application to [11C]Pittsburgh compound B (2013) (0)
- Lateral Amygdala Neurons Dopamine Induces a Slow Afterdepolarization in (2015) (0)
- Aggregating interests in aggregates: mechanistic, diagnostic and therapeutic implications of brain amyloidosis in neurodegenerative disorders among the elderly (2005) (0)
- Brain metabolic correlates of tau accumulation in progressive supranuclear palsy (2015) (0)
- [Evaluation of drug therapy based on the results of imaging]. (2004) (0)
- The analyze of four pedigrees with MAPT N279K mutation accompanying DAT scan and Tau imaging (2015) (0)
- Differences of distribution between RO 15-1788 and RO 15-4513 in vivo. (1991) (0)
- Dopamine Receptors in Schizophrenia (2002) (0)
- 90-25 Role of pulmonary binding site on pharmacokinetics of antidepressants measured by PET (1997) (0)
- [Neuroimaging of neuropsychiatric disorders]. (2012) (0)
- [Neural mechanisms of substance dependence]. (2010) (0)
- Human Brain Imaging of Dopamine D1 Receptors (2014) (0)
- Occupancy of dopamine transporter and the effect of dopamine reuptake inhibition by mazindol in living human brain (2013) (0)
- International Scientific Advisory Committee (2012) (0)
- IC-P-082 TAU AND ALPHA-SYNUCLEIN SELECTIVE BINDING COMPOUNDS DERIVED FROM APRINOIATHERAPEUTIC’S PM-PBB3 BINDING-SITE FOCUSED COMPOUND COLLECTION (2018) (0)
- Reproducibility of binding potential in a single PET scan with multiple injections of [11C]raclopride to evaluate dopamine release (2013) (0)
- Mitochondrial translocator protein (TSPO) ligand attenuates neuroinflammation and reduces complement component C1Q in a mouse model of tauopathy (2020) (0)
- Aberrant prefrontal activation during false recognition in chronic alcoholics: A functional MRI study (2001) (0)
- P2-079: Cortical amyloid deposition and parahippocampal atrophy in Alzheimer's disease and mild cognitive impairment (2008) (0)
- 216 – Functional abnormality of the extrastriate body area during observation of sports-related actions in chronic schizophrenia (2008) (0)
- BrainPET Poster Session: Molecular Brain Imaging—Clinical Applications (2009) (0)
- Comparative imaging between in vitro binding and in vivo PET (2010) (0)
- Quantification of dopamine synthesis in human brain using positron emission tomography with l-[beta-11C]DOPA (2006) (0)
- Preliminary analysis on DNA methylation status of marmoset model of psychiatric disorders with Infinium MethylationEPIC Kit (2017) (0)
- Molecular imaging of mental disorders (2007) (0)
- 1 In Vivo SPECT Imaging of Amyloid-Deposition with Radioiodinated Imidazo [ 1 , 2-a ] pyridine Derivative DRM 106 in Mouse Model of Alzheimer ’ s Disease (2014) (0)
- Differential Contribution of Dopaminergic Transmission at D1- and D2-like Receptors to Cost/Benefit Evaluation for Motivation in Monkeys (2020) (0)
- Neural correlates of manipulation process and semantic access in working memory (2000) (0)
- Lassen Award: Lassen Award Symposium (2009) (0)
- Dopamine D1receptorsinParkinson's disease andstriatonigral degeneration: apositron emission tomography study (2017) (0)
- Measurement Error Analysis for the Determination of Dopamine D2 Receptor Occupancy Using the Agonist Radioligand [11C]MNPA (2010) (0)
- P1-266: Changes in beta-amyloid deposition by pet study (2008) (0)
- Reply to Yang et al.: Gender is not a confounding factor of our result (2012) (0)
- Diabetes-related dementia is associated with tau pathology rather than amyloid pathology (2017) (0)
- New method of quantification of tau pathology with 11C-PBB3 PET using reference tissue extracted from cerebral cortical gray matter (2016) (0)
- Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity by PET (2011) (0)
- Healthy volunteer study using the helmet-neck PET prototype (2017) (0)
- Histamine H3 Receptor is correlated with neural activity of executive function (2015) (0)
- Kinetic analysis in healthy humans of [11C]PBR28, a new positron emission tomography radioligand to image the peripheral benzodiazepine receptor (2008) (0)
- Correction for Radiolabeled O-Methyl Metabolite in Human Brain (2012) (0)
- THE ROLE OF STEROID BIOSYNTHESIS IN THE PROTECTIVE ACTIONS OF LIGANDS FOR THE TRANSLOCATOR PROTEIN (TSPO) (2014) (0)
- Striatal and extrastriatal dopamine D2 receptor occupancy by the partial agonist antipsychotic drug aripiprazole in the human brain: a positron emission tomography study with [11C]raclopride and [11C]FLB457 (2012) (0)
- Synthesis and preliminary studies of a new nonpeptide antagonist for in vivo imaging of cholecystokinin‐a receptor (2001) (0)
- Relation between pre- and postsynaptic dopaminergic functions measured by PET: Implication of dopaminergic tone (2010) (0)
- Wavelet Denoising of Dynamic PET Data: Application to the Parametric Imaging of Peripheral Benzodiazepine Receptor (2006) (0)
- Erratum to “Impact of spillover from white matter by partial volume effect on quantification of amyloid deposition with [11C]PiB PET” [NeuroImage 143 (2016) 316–324] (2017) (0)
- Evaluation of reference tissue models for the quantitative analysis of [11C]PE2I binding in human brain (2006) (0)
- Representative immunofluorescence histological findings of tauopathy model mice and wild type mice. (2011) (0)
- The high‐affinity peripheral benzodiazepine receptor ligand [11C]DAA1106 can be used to image microglia in animal models of Parkinson's disease and neuroinflammation in vivo using PET. (2007) (0)
- Parametric visualisation and quantification of tau pathology in human brain using PET with [C-11]PBB3 (2015) (0)
- TAU ACCUMULATION PREDICTS PROGRESSION OF DEMENTIA IN SUBJECTS WITH EARLY ALZHEIMER’S DISEASE IN THE ALZHEIMER’S DISEASE SPECTRUM: A [11C]PBB3 POSITRON EMISSION TOMOGRAPHY STUDY (2018) (0)
- Quantification and reference optimization of tau PET imaging with [11C] PBB3 in PSP patients (2016) (0)
- [Usefulness of PET in clinical trials of psychotropic drugs]. (2005) (0)
- Relationship between neuromelanin-weighted MRI contrast and PET radiotracer binding to dopamine transporter in substantia nigra (2013) (0)
- Changes in dopaminergic function associated with low motivation in a primate model of hypothyroidism: a PET study (2011) (0)
- Lewy body disease with dementia can be well-differentiated from Alzheimer's disease by measurement of cerebral cortical acetylcholinesterase activity by PET (2010) (0)
- In vivo imaging of designer receptor that enables to modify reward-related behavior in monkeys (2014) (0)
- Correlation between dopamine synthesis and cell-level structure in human striate body using diffusion tensor imaging and positron emission tomography with L-[ β-11 C ] DOPA (2009) (0)
- Effective Biomarkers for Proof-of-Concept (2008) (0)
- BrainPET Poster Session: in vivo Pharmacology and Clinical Applications (2009) (0)
- In vivo detection of amyloid deposition using [11C]AZD2184 PET (2012) (0)
- Vocalization pattern analysis in the common marmosets (Callithrix jacchus);Novel method to classify emotional states of animals (2010) (0)
- In-vivo PET detection of neurodegenerative pathologies in a transgenic mouse model of tauopathies (2009) (0)
- Visualization of tau lesions in brains of tauopathy patients and model mice using tau ligand PBB3 (2014) (0)
- RADIOLIGAND BINDING ASSAYS FOR COMPARISON OF TAU PET PROBES, PBB3 AND T807, IN DETECTION OF TAU PATHOLOGIES IN ALZHEIMER'S DISEASE AND PSP BRAINS, AND NEUROTOXIC TAU SPECIES IN A TRANSGENIC MOUSE MODEL (2016) (0)
- Chronic treatment with serotonergic antidepressants alters both serotonin and dopamine receptor expressions in mouse hippocampus (2010) (0)
- PET examination of the monkey heart with high specific radioactivity [11C]norepinephrine and [11C]metaraminol. (1995) (0)
- Effect of lithium and anesthetics on in vivo binding of dopamine receptors. (1991) (0)
- Selective autophagy in neurons and its involvement in tau pathogenesis (2012) (0)
- [Significance of imaging biomarkers in exploratory clinical trials]. (2009) (0)
- Serotonergic Neurotransmission in Limbic Regions May Reflect Therapeutic Response of Depressive Patients: A PET Study with 11C-WAY-100635 and 18F-MPPF (2022) (0)
- Primary functional brain connections associated with melancholic major depressive disorder and modulation by antidepressants (2020) (0)
- PET molecular imaging of Psychiatric Disorders (2008) (0)
- Alteration of dopaminergic function in a primate model of hypothyroidism revealed by PET (2011) (0)
- Quantitative assessment of prenatal X-ray exposure using longitudinal gadolinium-, manganese-enhanced and perfusion MRI in neonatal rats (2009) (0)
- Brain PET Oral 4: in vivo Pharmacology I—Dopamine and Norepinephrine (2009) (0)
- 13. The preliminary phantom study for in vivo pharmacokinetics of antipsycotic drug fluvoxamine using commercial MRI system 19F-MRS (2001) (0)
- Evaluation of radiotherapy using Manganese-enhanced MRI ( MEMRI ) (2009) (0)
- PIVOTAL ROLES OF P62 AND SELECTIVE AUTOPHAGY IN NEURODEGENERATION REVEALED WITH TAUOPATHY MOUSE MODELS (2014) (0)
- Assessment of neuroinflammation in a mouse model of obesity and β-amyloidosis using PET (2016) (0)
- IN VIVO TRACKING OF TAU PATHOLOGIES WITH 18F-PM-PBB3 (18F-APN-1607) PET IN AD AND DIVERSE NON-AD TAUOPATHIES (2019) (0)
- BrainPET Poster Session: Radiotracers and Quantification (2009) (0)
- VISUALIZATION OF MICROGLIAL RESPONSE TO TAU-INDUCED NEURODEGENERATION IN A MODEL OF TAUOPATHY (2017) (0)
- Comparison of image reconstruction methods in estimating of human neuroreceptor binding with PET (2008) (0)
- [Molecular imaging in the drug development of psychotropics using positron emission tomography]. (2007) (0)
- 2.022 EFFECT OF PRAMIPEXOLE ON REGIONAL CEREBRAL BLOOD FLOW IN PARKINSON'S DISEASE (2012) (0)
- Tau deposition estimated by [11C]PBB3 PET in Alzheimer’s disease, MCI with and without amyloid deposition, and cognitive healthy subjects (2014) (0)
- Effects of the partial agonist antipsychotic drug aripiprazole on dopamine synthesis in humans measured by PET with [C-11]DOPA (2012) (0)
- Neuroscience Committee (2008) (0)
- Conformational heterogeneity of tau lesions captured by PET and its clinical significance (2016) (0)
- Effects of antipsychotic drug on dopamine synthesis in humans measured by PET with [C-11]DOPA (2009) (0)
- TAU AND ALPHA-SYNUCLEIN SELECTIVE BINDING COMPOUNDS DERIVED FROM APRINOIA THERAPEUTIC’S PM-PBB3 BINDING-SITE FOCUSED COMPOUND COLLECTION (2018) (0)
- Significance of 18-kDa translocator protein in monitoring and regulating microglial response to Aβ amyloidosis: An in vivo PET study of microglia-implanted mouse models (2010) (0)
- Influence of maternal immune activation in embryonic stage on hippocampal function in juvenile stage (2009) (0)
- Reproducibility of [11C]MNPA binding in healthy human subjects (2010) (0)
- Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys (2020) (0)
- Resting-state functional connectivity relates to interindividual variations in positive memory. (2021) (0)
- P-059 Voxel-based analysis of [11C]PIB uptake in Alzheimer’s disease and mild cognitive impairment (2007) (0)
- PET IMAGING OF SYNERGISTIC, BUT MODALLY DISTINCT, OBESITY- AND Aβ-TRIGGERED ABNORMALITIES IN CEREBRAL GLUCOSE METABOLISM AND GLIOSIS IN MICE (2014) (0)
- Roles of hippocampal and prefrontal dopamine D1 and D2 receptors in human neurocognitive functions (2008) (0)
- Lewy Body Disease With Dementia can be Well-Differentiated from Alzheimer's Disease By Measurement of Cerebral Cortical Acetylcholinesterase Activity by PET (2010) (0)
- Performance prediction of candidate PET ligands for central histamine H3 receptor by liquid chromatography-tandem mass spectrometry (2014) (0)
- Quantitative multi-parametric assessment of a radiation-induced encepholodysplasia CNS model using magnetic resonance imaging (2010) (0)
- Serotonergic neural network related to behavioral inhibition system (2021) (0)
- Quantitative analysis of NK1 receptor binding in human brain using PET with [18F]FE-SPA-RQ (2008) (0)
- A biological homology between a rodent model of maternal immune activation and schizophrenia patients: A comparative study using positron emission tomography and immune histochemistry (2011) (0)
- P1-277 SPECT IMAGING FOR AMYLOID PLAQUESWITH A NOVEL RADIOIODINATED LIGAND IN AN ALZHEIMER’S DISEASE MODEL (2014) (0)
- Reduction of dopmamine D2 receptor binding in medial prefrontal cortex in schizophrenia animal model with maternal immune activation (2010) (0)
- [Effect of menopause on morphological changes of the brain in schizophrenia]. (2013) (0)
- TAU AND ALPHA-SYNUCLEIN SELECTIVE BINDING COMPOUNDS DERIVED FROM APRINOIA THERAPEUTIC’S PM-PBB3 BINDING-SITE FOCUSED COMPOUND COLLECTION (2018) (0)
- A tau PET study of primary age‐related tauopathy in healthy volunteers (2020) (0)
- CORRELATION BETWEEN SEVERITY OF PARKINSONISM AND DOPAMINE NEURONAL DAMAGE IN MPTP-TREATED MARMOSETS (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Tetsuya Suhara?
Tetsuya Suhara is affiliated with the following schools: